Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative 1H MR Spectroscopy1

HM Baek, JH Chen, K Nie, HJ Yu, S Bahri, RS Mehta… - Radiology, 2009 - pubs.rsna.org
Purpose: To compare changes in the concentration of choline-containing compounds (tCho)
and in tumor size at follow-up after neoadjuvant chemotherapy (NAC) between patients who …

Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method

M Tozaki, M Sakamoto, Y Oyama… - Journal of Magnetic …, 2010 - Wiley Online Library
Purpose: To assess the efficacy of quantitative 1H MR spectroscopy (MRS) using the
external standard method to predict the pathological response to neoadjuvant …

MR spectroscopy of breast cancer for assessing early treatment response: results from the ACRIN 6657 MRS trial

PJ Bolan, E Kim, BA Herman… - Journal of Magnetic …, 2017 - Wiley Online Library
Purpose To estimate the accuracy of predicting response to neoadjuvant chemotherapy
(NACT) in patients with locally advanced breast cancer using MR spectroscopy (MRS) …

Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy

EMS Negrão, JA Souza, EF Marques… - European Journal of …, 2019 - Elsevier
Purpose To evaluate which factors may influence magnetic resonance imaging (MRI)
performance in the detection of pathologic complete response (pCR) after neoadjuvant …

Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy

JH Chen, MY Su - BioMed research international, 2013 - Wiley Online Library
Neoadjuvant chemotherapy (NAC), also termed primary, induction, or preoperative
chemotherapy, is traditionally used to downstage inoperable breast cancer. In recent years it …

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo 1H MR Spectroscopy—A Pilot Study at 4 T1

S Meisamy, PJ Bolan, EH Baker, RL Bliss, E Gulbahce… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To determine if changes in the concentration of choline-containing compounds
(tCho) from before primary systemic therapy (PST) to within 24 hours after the first treatment …

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer

B Goorts, KMA Dreuning, JB Houwers… - Breast Cancer …, 2018 - Springer
Background The main purpose was to investigate the correlation between magnetic
resonance imaging (MRI)-based response patterns halfway through neoadjuvant …

MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy

N Hylton - Magnetic Resonance Imaging Clinics, 2006 - mri.theclinics.com
The NSABP B-18 trial, a randomized study comparing pre-and postoperative chemotherapy
in women with operable breast cancer, found no statistically significant difference in overall …

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted …

A Fangberget, LB Nilsen, KH Hole, MM Holmen… - European …, 2011 - Springer
Objective To explore the predictive value of MRI parameters and tumour characteristics
before neoadjuvant chemotherapy (NAC) and to compare changes in tumour size and …

Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes

J Kim, BK Han, EY Ko, ES Ko, JS Choi, KW Park - European Radiology, 2022 - Springer
Objectives This study aimed to investigate the predictability of breast MRI for pathologic
complete response (pCR) by molecular subtype in patients with breast cancer receiving …